Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Invitrx Therapeutics Inc.
FDA Inspection
•Invitrx Therapeutics Inc.•April 3, 2019

Invitrx Therapeutics Inc. – FDA Inspection, Apr 3, 2019

Record Details

This FDA Inspection record concerns Invitrx Therapeutics Inc., with an inspection on April 3, 2019, issued by the Center for Biologics Evaluation and Research, covering biologics.

Company
Invitrx Therapeutics Inc.
Inspection Date
April 3, 2019
Product Type
Biologics
Office
Center for Biologics Evaluation and Research
People
  • Laurissa S. Flowers (Issuing Officer)
  • Scott T. Ballard (FDA Associated Person)
View Company Profile

ID · 20c71ece-e5a6-4774-b48c-b6c6ac511713

Inspection Facts

Official Action Indicated (OAI)

Significant objectionable conditions were found and regulatory or administrative action is recommended.

Inspection number
1084910
FDA center
Biologics
Project area
Human Cellular, Tissue, and Gene Therapies
Outcome
Form 483 issued
Enforcement
Warning Letter

FDA Citations

14
  1. 21 CFR 211.42(c)(10)(iv)Environmental Monitoring System
  2. 21 CFR 211.160(b)(3)Acceptance of drug products
  3. 21 CFR 1271.75(a)(1)Risk factors, clinical evidence
  4. 21 CFR 211.84(a)Components withheld from use pending release
  5. 21 CFR 211.25(a)Training , Education , Experience overall
  6. 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
  7. 21 CFR 1271.50(a)Determination based on screening and testing
  8. 21 CFR 211.198(a)Complaint Handling Procedure
  9. 21 CFR 211.113(b)Procedures for sterile drug products
  10. 21 CFR 211.42(c)(5)Mfg / Processing Operations Area

Showing 10 of 14 citations.

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Invitrx Therapeutics Inc.

3
DateClassificationOfficeProject area
April 30, 2025Not classifiedLos Angeles District OfficeHuman Cellular, Tissue, and Gene Therapies
March 22, 2022OAICenter for Biologics Evaluation and ResearchHuman Cellular, Tissue, and Gene Therapies
September 13, 2019VAICenter for Food Safety and Applied NutritionColors and Cosmetics Technology
Other documents for Invitrx Therapeutics Inc.
  • FDA Inspection 1265382 - 2025-04-30
  • FDA Inspection 1165854 - 2022-03-22
  • FDA Inspection 1101970 - 2019-09-13

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Invitrx Therapeutics Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.